Quillivant ER (methylphenidate hydrochloride)
pCPA File Number:
23595
Negotiation Status:
Active Negotiation
Indication(s):
Attention-deficit/hyperactivity disorder (ADHD)
Sponsor/Manufacturer:
KYE Pharmaceuticals Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable